MAPT and Alzheimer disease: In their latest 2018 paper, however, they again complicate things by proposing a distinction between “Alzheimer’s pathological change” (if only evidence for Aβ accumulation is present) and “Alzheimer’s disease” (when there is also evidence for tau-pathology).